Taiwan FDA registration 35eb5fcb2d381216be21887e94d374d1
"BioMérieux" Leifke Next Generation Quality Control Strains (Unsterilized)
TW: "生物梅里埃" 萊弗克新一代品管菌株 (未滅菌)
Taiwan·Risk Class 1·BIOMERIEUX SA·Registered Dec 21, 2012 – Dec 21, 2017CancelledRegistration details
- Analysis ID
- 35eb5fcb2d381216be21887e94d374d1
- Customs Code
- DHA04401251108
Company information
- Manufacturer
- BIOMERIEUX SA
- Manufacturer Country
- France
- Authorized Representative
- Hong Kong Commercial Mérieux S.p.A. Taiwan Branch
Product details
- Intended Use
- Limited to the first level identification range of the quality management equipment group (C.2480) of the culture medium for the management of medical devices.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.2480 培養基的品質管制器材組
- Import Information
- import
Dates and status
- Registration Date
- Dec 21, 2012
- Expiry Date
- Dec 21, 2017
- Cancellation Date
- Nov 18, 2019
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for "BioMérieux" Leifke Next Generation Quality Control Strains (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 35eb5fcb2d381216be21887e94d374d1 and manufactured by BIOMERIEUX SA. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices